Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells
Ys. Chi et al., Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells, BIOCH PHARM, 61(10), 2001, pp. 1195-1203
Plant flavonoids show anti-inflammatory activity both in vitro and in vivo.
Some flavonoids, such as flavone derivatives, have been reported previousl
y to inhibit nitric oxide (NO) production by suppressing inducible nitric o
xide synthase (iNOS) expression. In this investigation. the effects of wogo
nin, a potent inhibitor of NO production among the flavonoids tested, on cy
clooxygenase-2 (COX-2) induction and activity were elucidated further in co
nnection with iNOS, using a mouse macrophage cell line, RAW 264.7. Wogonin
inhibited NO and prostaglandin E-2 (PGE(2)) production from lipopolysacchar
ide-induced RAW cells with IC50 values of 31 and 0.3 muM, respectively. Whe
n added after the induction of iNOS and COX-2. wogonin inhibited the format
ion of PGE(2) (IC50 = 0.8 muM), but not the production of NO. Wogonin inhib
ited COX-2 activity directly (IC50 = 46 muM) from the homogenate of aspirin
-pretreated RAW cells, as determined by measuring [C-14]PGE(2) formation fr
om [C-14]arachidonic acid. However, it did not inhibit iNOS or phospholipas
e A(2) activity. Western blotting showed that wogonin suppressed the induct
ion of both iNOS and COX-2. Prednisolone also suppressed the induction of i
NOS and COX-2. Whereas RU-486 (a steroid receptor antagonist) reversed the
suppressive activity of prednisolone, it did not affect the suppressive act
ivity of wogonin, suggesting that the suppressive activity of wogonin is no
t mediated by binding to a steroid receptor. Results from the present study
demonstrated that wogonin is a direct COX-2 inhibitor, as well as an inhib
itor of iNOS and COX-2 induction. Wogonin may be a potential agent for use
in the treatment of inflammatory diseases. (C) 2001 Elsevier Science Inc. A
ll rights reserved.